Ignite Creation Date:
2024-05-06 @ 2:20 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02026934
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2016-11-21
First Post:
2014-01-02
Brief Title:
CliniMACS CD34 Reagent System for Expanded Access Use
Sponsor:
Joseph Antin
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
13-024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joseph Antin
Lead Sponsor Class:
OTHER
Responsible Party:
Joseph Antin
Responsible Party Title:
SponsorCo-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Miltenyi Biomedicine GmbH | INDUSTRY |